You are on page 1of 3

DRUG STUDY

CRITERIA:
Content and organization 40%
Analysis 40%
Neatness and promptness 10%
Reference 10%
DAVAO DOCTORS COLLEGE TOTAL 100%
General Malvar St., Davao
City Nursing Program

Name of Patient: Patient X Date of Admission: September 5, 2023 Room: 303


Age: 79 years old Sex: Male Civil Status: N/A Attending Physician: Dr.
Generalao

DRUG NAME CLASSIFICATION / INDICATION CONTRAINDICATIONS SIDE


MECHANISM OF
ACTION

BRAND NAME: MOA: Inflammatory  Hypersensitivit EENT: ti


BAYER - Produce disorders including: y to aspirin or
analgesia and other
reduce
 Rheumatoid salicylates SKIN: ra
inflammation
and fever by arthritis  Cross-
inhibiting the  Osteoarthritis sensitivity with
production of  Mild to other NSAIDs HEMA:
prostaglandins. moderate pain may exist (less hemoly
- Decreases  Fever with non-
platelet aspirin
 Prophylaxis of
aggregation.
GENERIC NAME: transient salicylates)
- Decreased GI: G
ASPIRIN incidence of ischemic  Bleeding dyspep
(ACETYLSALICYLIC transient attacks disorders or epigast
ACID, ASA) ischemic  Myocardial thrombocytope nausea
attacks and infarction nia pain,
myocardial  Pedi: may
infarction hepato
increase risk of
Reye’s vomitin
syndrome in
REFERENCES: children or
THERAPEUTIC CLASS: Nursing 2023 Drug
adolescents Others:
NSAID’s Handbook
with viral reactio
infections. anaphy
PHARMACOLOGIC
CLASS: SALICYLATES larynge

DOSAGE: 80 mg

ROUTE: ORAL

FREQUENCY: ONCE
DAILY p.c lunch
Irish T. Cacayan

BBN/DTS/2020
Name of Student

You might also like